Quarterly report · Q2
2533.TEDINET S100OTCV
Period2022-01-01 → 2022-06-30
Filed2022-08-05
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 46
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥38.4bn | 2022-01-01 → 2022-06-30 | Cons. | Net sales |
| Revenue | ¥78.6bn | 2021-01-01 → 2021-12-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥38.0bn | 2021-01-01 → 2021-06-30 | Cons. | Net sales |
| Operating income | −¥147m | 2022-01-01 → 2022-06-30 | Cons. | Operating income |
| Operating income | ¥825m | 2021-01-01 → 2021-06-30 | Cons. | Operating income |
| Ordinary income | −¥77m | 2022-01-01 → 2022-06-30 | Cons. | Ordinary income |
| Ordinary income | ¥1.3bn | 2021-01-01 → 2021-12-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥867m | 2021-01-01 → 2021-06-30 | Cons. | Ordinary income |
| Profit before tax | −¥182m | 2022-01-01 → 2022-06-30 | Cons. | Income before income taxes |
| Profit before tax | ¥779m | 2021-01-01 → 2021-06-30 | Cons. | Income before income taxes |
| Net income (owners) | −¥744m | 2022-01-01 → 2022-06-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥299m | 2021-01-01 → 2021-12-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥558m | 2021-01-01 → 2021-06-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | −¥821m | 2022-01-01 → 2022-06-30 | Cons. | Profit loss |
| Net income | ¥563m | 2021-01-01 → 2021-06-30 | Cons. | Profit loss |
| Total assets | ¥50.3bn | at 2022-06-30 | Cons. | Assets |
| Total assets | ¥52.3bn | at 2021-12-31 | Cons. | Assets |
| Total assets | ¥51.0bn | at 2021-06-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥29.3bn | at 2022-06-30 | Cons. | Liabilities |
| Total liabilities | ¥30.2bn | at 2021-12-31 | Cons. | Liabilities |
| Net assets / equity | ¥21.0bn | at 2022-06-30 | Cons. | Net assets |
| Net assets / equity | ¥22.0bn | at 2021-12-31 | Cons. | Net assets |
| Net assets / equity | ¥22.3bn | at 2021-06-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥844m | at 2022-06-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥990m | at 2021-12-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥839m | at 2022-06-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥986m | at 2021-12-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥779m | at 2021-06-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥910m | at 2020-12-31d | Cons. | Cash and cash equivalents |
| Operating cash flow | −¥2.6bn | 2022-01-01 → 2022-06-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥1.6bn | 2021-01-01 → 2021-12-31 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | −¥2.9bn | 2021-01-01 → 2021-06-30 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥1.9bn | 2022-01-01 → 2022-06-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥2.9bn | 2021-01-01 → 2021-12-31 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥2.5bn | 2021-01-01 → 2021-06-30 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | ¥4.4bn | 2022-01-01 → 2022-06-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | ¥1.4bn | 2021-01-01 → 2021-12-31 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥5.2bn | 2021-01-01 → 2021-06-30 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥-12.53 | 2022-01-01 → 2022-06-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-10.1 | 2022-04-01 → 2022-06-30d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥5.03 | 2021-01-01 → 2021-12-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥9.4 | 2021-01-01 → 2021-06-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥6.71 | 2021-04-01 → 2021-06-30d | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 37.9% | at 2022-06-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 38.3% | at 2021-12-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 39.7% | at 2021-06-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 44
| Segment | Item | Period | Value |
|---|---|---|---|
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2022-01-01 → 2022-06-30 | ¥37m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2022-01-01 → 2022-06-30 | ¥37m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2022-01-01 → 2022-06-30 | ¥7m |
| Reconciling Itemsreconciling | revenue | 2022-01-01 → 2022-06-30 | ¥0 |
| Reconciling Itemsreconciling | revenue intersegment | 2022-01-01 → 2022-06-30 | ¥0 |
| jpcrp040300-q2r_E00397-000Enzymatic Medicinereportable segment | revenue | 2022-01-01 → 2022-06-30 | ¥1.9bn |
| jpcrp040300-q2r_E00397-000Enzymatic Medicinereportable segment | revenue external | 2022-01-01 → 2022-06-30 | ¥1.9bn |
| jpcrp040300-q2r_E00397-000Enzymatic Medicinereportable segment | segment profit | 2022-01-01 → 2022-06-30 | ¥338m |
| jpcrp040300-q2r_E00397-000Liquorreportable segment | revenue | 2022-01-01 → 2022-06-30 | ¥34.2bn |
| jpcrp040300-q2r_E00397-000Liquorreportable segment | revenue external | 2022-01-01 → 2022-06-30 | ¥34.2bn |
| jpcrp040300-q2r_E00397-000Liquorreportable segment | revenue intersegment | 2022-01-01 → 2022-06-30 | ¥0 |
| jpcrp040300-q2r_E00397-000Liquorreportable segment | segment profit | 2022-01-01 → 2022-06-30 | −¥446m |
| jpcrp040300-q2r_E00397-000Real Estatereportable segment | revenue | 2022-01-01 → 2022-06-30 | ¥190m |
| jpcrp040300-q2r_E00397-000Real Estatereportable segment | revenue external | 2022-01-01 → 2022-06-30 | ¥190m |
| jpcrp040300-q2r_E00397-000Real Estatereportable segment | segment profit | 2022-01-01 → 2022-06-30 | ¥102m |
| jpcrp040300-q2r_E00397-000Starch For Processingreportable segment | revenue | 2022-01-01 → 2022-06-30 | ¥2.1bn |
| jpcrp040300-q2r_E00397-000Starch For Processingreportable segment | revenue external | 2022-01-01 → 2022-06-30 | ¥2.1bn |
| jpcrp040300-q2r_E00397-000Starch For Processingreportable segment | segment profit | 2022-01-01 → 2022-06-30 | −¥149m |
| —segment total | revenue | 2022-01-01 → 2022-06-30 | ¥38.3bn |
| —segment total | revenue external | 2022-01-01 → 2022-06-30 | ¥38.3bn |
| —segment total | revenue intersegment | 2022-01-01 → 2022-06-30 | ¥0 |
| —segment total | segment profit | 2022-01-01 → 2022-06-30 | −¥154m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2021-01-01 → 2021-06-30 | ¥34m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2021-01-01 → 2021-06-30 | ¥34m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2021-01-01 → 2021-06-30 | ¥6m |
| Reconciling Itemsreconciling | revenue | 2021-01-01 → 2021-06-30 | −¥1m |
| Reconciling Itemsreconciling | revenue intersegment | 2021-01-01 → 2021-06-30 | −¥1m |
| jpcrp040300-q2r_E00397-000Enzymatic Medicinereportable segment | revenue | 2021-01-01 → 2021-06-30 | ¥1.9bn |
| jpcrp040300-q2r_E00397-000Enzymatic Medicinereportable segment | revenue external | 2021-01-01 → 2021-06-30 | ¥1.9bn |
| jpcrp040300-q2r_E00397-000Enzymatic Medicinereportable segment | segment profit | 2021-01-01 → 2021-06-30 | ¥431m |
| jpcrp040300-q2r_E00397-000Liquorreportable segment | revenue | 2021-01-01 → 2021-06-30 | ¥34.0bn |
| jpcrp040300-q2r_E00397-000Liquorreportable segment | revenue external | 2021-01-01 → 2021-06-30 | ¥34.0bn |
| jpcrp040300-q2r_E00397-000Liquorreportable segment | revenue intersegment | 2021-01-01 → 2021-06-30 | ¥1m |
| jpcrp040300-q2r_E00397-000Liquorreportable segment | segment profit | 2021-01-01 → 2021-06-30 | ¥296m |
| jpcrp040300-q2r_E00397-000Real Estatereportable segment | revenue | 2021-01-01 → 2021-06-30 | ¥171m |
| jpcrp040300-q2r_E00397-000Real Estatereportable segment | revenue external | 2021-01-01 → 2021-06-30 | ¥171m |
| jpcrp040300-q2r_E00397-000Real Estatereportable segment | segment profit | 2021-01-01 → 2021-06-30 | ¥88m |
| jpcrp040300-q2r_E00397-000Starch For Processingreportable segment | revenue | 2021-01-01 → 2021-06-30 | ¥1.9bn |
| jpcrp040300-q2r_E00397-000Starch For Processingreportable segment | revenue external | 2021-01-01 → 2021-06-30 | ¥1.9bn |
| jpcrp040300-q2r_E00397-000Starch For Processingreportable segment | segment profit | 2021-01-01 → 2021-06-30 | ¥2m |
| —segment total | revenue | 2021-01-01 → 2021-06-30 | ¥37.9bn |
| —segment total | revenue external | 2021-01-01 → 2021-06-30 | ¥37.9bn |
| —segment total | revenue intersegment | 2021-01-01 → 2021-06-30 | ¥1m |
| —segment total | segment profit | 2021-01-01 → 2021-06-30 | ¥819m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 577
| Item | Context | Value | Unit |
|---|---|---|---|
| Regulations in accordance with which consolidated financial statements have been prepared financial information | CurrentYTDDuration | Text · Plus | |
| Note on independent audit financial information | CurrentYTDDuration | Text · Plus | |
| Quarterly consolidated balance sheet (text) | CurrentYTDDuration | Text · Plus | |
| Year to quarter end consolidated statement of income (text) | CurrentYTDDuration | Text · Plus | |
| Year to quarter end consolidated statement of comprehensive income (text) | CurrentYTDDuration | Text · Plus | |
| Quarterly consolidated statement of cash flows (text) | CurrentYTDDuration | Text · Plus | |
| Notes changes in accounting policies in accordance with changes in accounting standards etc quarterly consolidated financial statements (text) | CurrentYTDDuration | Text · Plus | |
| Notes additional information quarterly consolidated financial statements (text) | CurrentYTDDuration | Text · Plus | |
| Notes regarding promissory notes due on balance sheet date (text) | CurrentQuarterInstant | Text · Plus | |
| Notes regarding guarantee obligations (text) | CurrentQuarterInstant | Text · Plus | |
| Notes regarding liquidation of accounts receivable (text) | CurrentQuarterInstant | Text · Plus | |
| Notes regarding financial covenant (text) | CurrentQuarterInstant | Text · Plus | |
| Major components of selling general and administrative expenses (text) | CurrentYTDDuration | Text · Plus | |
| Notes regarding loss on disposal and sales of property plant and equipment noe (text) | CurrentYTDDuration | Text · Plus | |
| A recall related loss (text) | CurrentYTDDuration | Text · Plus | |
| Reconciliation of ending balance of cash and cash equivalents with account balances per balance sheet (text) | CurrentYTDDuration | Text · Plus | |
| Notes regarding dividend (text) | Prior1YTDDuration | Text · Plus | |
| Notes regarding dividend (text) | CurrentYTDDuration | Text · Plus | |
| Notes segment information etc quarterly consolidated financial statements (text) | CurrentYTDDuration | Text · Plus | |
| Footnotes regarding segment information table (text) | Prior1YTDDuration | Text · Plus | |
| Footnotes regarding segment information table (text) | CurrentYTDDuration | Text · Plus | |
| Disclosure of changes etc in reportable segments (text) | CurrentYTDDuration | Text · Plus | |
| Notes revenue recognition quarterly consolidated financial statements (text) | CurrentYTDDuration | Text · Plus | |
| Notes per share information quarterly consolidated financial statements (text) | CurrentYTDDuration | Text · Plus | |
| Notes significant events after reporting period quarterly consolidated financial statements (text) | CurrentYTDDuration | Text · Plus | |
| Other information consolidated financial statements etc (text) | CurrentYTDDuration | Text · Plus | |
| Information about company which provides guarantee to reporting company (text) | FilingDateInstant | Text · Plus |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |